| Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome DB Meya, S Okurut, G Zziwa, MA Rolfes, M Kelsey, S Cose, M Joloba, ... The Journal of infectious diseases 211 (10), 1597-1606, 2015 | 66 | 2015 |
| Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans MA Eller, KG Blom, VD Gonzalez, LA Eller, P Naluyima, O Laeyendecker, ... PloS one 6 (4), e18779, 2011 | 54 | 2011 |
| Terminal effector CD8 T cells defined by an IKZF2+ IL-7R− transcriptional signature express FcγRIIIA, expand in HIV infection, and mediate potent HIV-specific antibody … P Naluyima, KG Lal, MC Costanzo, GH Kijak, VD Gonzalez, K Blom, ... The Journal of Immunology 203 (8), 2210-2221, 2019 | 30 | 2019 |
| Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting RE Olemukan, LA Eller, BJ Ouma, B Etonu, S Erima, P Naluyima, ... Clinical and Vaccine Immunology 17 (6), 910-918, 2010 | 27 | 2010 |
| Impaired natural killer cell responses are associated with loss of the highly activated NKG2A+ CD57+ CD56dim subset in HIV-1 subtype D infection in Uganda P Naluyima, MA Eller, O Laeyendecker, TC Quinn, D Serwadda, ... Aids 28 (9), 1273-1278, 2014 | 24 | 2014 |
| Brucellosis: Community, medical and veterinary workers’ knowledge, attitudes, and practices in Northern Uganda HM Nabirye, J Erume, GW Nasinyama, JM Kungu, J Nakavuma, ... Int J One Health, 2017 | 21 | 2017 |
| The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: capabilities for high-consequence pathogen clinical research P Naluyima, W Kayondo, C Ritchie, J Wandege, S Kagabane, ... PLoS Neglected Tropical Diseases 13 (12), e0007787, 2019 | 11 | 2019 |
| Brief report: differential associations of interleukin 6 and intestinal fatty acid-binding protein with progressive untreated HIV-1 infection in Rakai, Uganda OA Olwenyi, P Naluyima, F Cham, TC Quinn, D Serwadda, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 72 (1), 15-20, 2016 | 11 | 2016 |
| In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion OA Olwenyi, B Asingura, P Naluyima, GU Anywar, J Nalunga, ... BMC complementary medicine and therapies 21, 1-14, 2021 | 9 | 2021 |
| Differential loss of invariant natural killer T cells and FoxP3+ regulatory T cells in HIV-1 subtype A and subtype D infections B Flach, P Naluyima, K Blom, VD Gonzalez, LA Eller, O Laeyendecker, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 63 (3), 289-293, 2013 | 9 | 2013 |
| Sex and urbanicity contribute to variation in lymphocyte distribution across Ugandan populations P Naluyima, LA Eller, BJ Ouma, D Kyabaggu, P Kataaha, D Guwatudde, ... PLoS One 11 (1), e0146196, 2016 | 6 | 2016 |
| Pre-positioned outbreak research: the joint medical emerging diseases intervention clinical capability experience in Uganda KA Martins, RR Ayebare, N Bhadelia, F Kiweewa, P Waitt, D Mimbe, ... Health security 18 (2), 114-124, 2020 | 4 | 2020 |
| Ontogeny of CD4+ T Lymphocytes With Phenotypic Susceptibility to HIV-1 During Exclusive and Nonexclusive Breastfeeding in HIV-1–Exposed Ugandan Infants EJ McFarland, TM Powell, C Onyango-Makumbi, W Zhang, K Melander, ... The Journal of Infectious Diseases 215 (3), 368-377, 2017 | 4 | 2017 |
| Transitioning women with human immunodeficiency virus to first-line preferred regimen of tenofovir disoproxil fumarate, lamivudine, and dolutegravir in Sub-Saharan Africa N Shah, A Esber, JS Cavanaugh, P Agaba, N Dear, M Iroezindu, ... Clinical Infectious Diseases 76 (3), e766-e772, 2023 | 1 | 2023 |
| Developing capacity for implementation and evaluation of vaccine trials in Uganda: Perspective of the Makerere University Walter Reed Project P Naluyima, B Mwesigwa, A Tindikahwa, S Mugamba, JT Ssensamba, ... African Health Sciences 22 (2), 34-41., 2022 | 1 | 2022 |
| Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study I Kroidl, MIM Ahmed, S Horn, C Polyak, A Esber, A Parikh, LA Eller, ... Eclinicalmedicine 49, 2022 | 1 | 2022 |
| Terminally differentiated CD8 effector T cells have NK-like features and are potent mediators of HIV-specific ADCC KG Lal, P Naluyima, MC Costanzo, GH Kijak, LA Eller, M Creegan, ... The Journal of Immunology 198 (1_Supplement), 125.4-125.4, 2017 | 1 | 2017 |
| Differential associations of IL-6 and intestinal fatty acid-binding protein with progressive untreated HIV-1 infection in Rakai, Uganda OA Olwenyi, P Naluyima, F Cham, TC Quinn, D Serwadda, ... Journal of acquired immune deficiency syndromes (1999) 72 (1), 15, 2016 | 1 | 2016 |
| 1169. Derivation And Validation of an International Clinical Prognostication Model for 28-day Sepsis Mortality. PW Blair, R Mehta, T Som, S Okello, EL Tsalik, A Wailagala, CW Woods, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1006, 2022 | | 2022 |
| Training Needs for Emerging Infectious Diseases Research, Surveillance and Control in High-Risk and Resource-Constrained Settings: Findings and Recommendations for Uganda B Asingura, F Kiweewa, D Kaawa-Mafigiri, S Achabo, D Mimbe, AE Okullo, ... ResearchSquare, 2022 | | 2022 |
